Verve Therapeutics VERV 深 沪
已收盘 07-25 16:00:00 美东时间
11.13
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 11.13
- 总市值 9.94亿
- 52周最高 11.405
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 2.8647
- 委 比 0.00%
- 总股本 8931.22万
- 历史最高 78.00
- 量 比 0
- 振 幅 0.00%
- 历史最低 2.8647
- 每 手 1
- 风险率 1.97%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Verve Therapeutics Announces Merger and Nasdaq Delisting
Verve Therapeutics ( ($VERV) ) just unveiled an update. Verve Therapeutics has ...
07-26 04:51
Eli Lilly And Verve Therapeutics Announces That The Tender Offer For All Outstanding Verve Shares, Priced At $10.50 Per Share In Cash Plus A Potential Additional $3.00 Via A Non-Tradable Contingent Value Right, Officially Expired At 12:01 A.M. Et On July 24, 2025. The Offer Was Not Extended.
Eli Lilly and Company (NYSE:LLY) and Verve Therapeutics, Inc. (NASDAQ:VERV) today announced that the tender offer to purchase all of the issued and outstanding shares ("Shares") of Verve's common stock in exchange for
07-24 20:05
Verve Therapeutics Announces Retention Bonus Program for Executives
Verve Therapeutics ( ($VERV) ) has shared an announcement. Verve Therapeutics a...
07-15 18:45
200%税率威胁下 这一美国关税“高危”行业为何还能涨？
①当一位美国总统威胁要对你的行业征收200%的关税时，这通常不是什么好消息； ②然而，自上周二美国总统特朗普在内阁会议上表示将对进口药品征收巨额关税以来，该行业的高管和投资者们，却似乎并没有流露出过多恐慌的情绪……
07-14 11:26
Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies
Donald Trump's proposed 200% tariffs can squeeze the profit margins of pharma companies, but LLY is poised to "benefit" except for the rest.
07-11 19:57
14 Top Press Releases from June
Including Michaels acquiring JOANN, top university rankings, and seasonal news from both Whataburger and Spirit Halloween. NEW YORK, July 11, 2025 /PRNewswire/ -- With thousands of press rel...
07-11 18:02
Prime Medicine soars as Jones sees it as an acquisition target
Prime Therapeutics (NASDAQ:PRME) skyrocketed ~35% Monday after JonesTrading issued a bullish report on the company due to increased interest in gene editing in the wake of Eli Lilly's (NYSE:LLY) deal ...
07-08 00:33
美股大行评级 | 潜在涨幅205.56%！康托·菲茨杰拉德上调HIVE Digital Technologies目标价至5.5美元，维持"超配"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1145638202455883776.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 康托·菲茨杰拉德：维持HIVE Digital Technologies(HIVE)"超配"评级，目标价从5美元升至5.5美元</p> <p>• BTIG：维持Theravance Biopharma(TBPH)"买入"评
06-28 08:37
BMO Capital Downgrades Verve Therapeutics to Market Perform, Lowers Price Target to $13.5
BMO Capital analyst Kostas Biliouris downgrades Verve Therapeutics (NASDAQ:VERV) from Outperform to Market Perform and lowers the price target from $20 to $13.5.
06-28 01:09
细胞和基因治疗临床试验激增42%！115项研究引领全球创新浪潮
（转自：动脉新医药） 6月19日，国家药监局药品审评中心发布了《中国新药注册临床试验进展年度报告（2024年）》（以下简称《报告》）。《报告》从临床试验登记总体...
06-24 15:36
